Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
Clinical trial NCT05184595 · UNKNOWN
Trial details
- NCT number
- NCT05184595
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-03-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.